Cargando…
Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome
The Grade group is an important parameter for clinical decision-making in prostate cancer. Recently, percent Gleason pattern 4 and presence of invasive cribriform and/or intraductal carcinoma (CR/IDC) have been recognized for their independent predictive value for prostate cancer outcome. There is s...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969485/ https://www.ncbi.nlm.nih.gov/pubmed/32815034 http://dx.doi.org/10.1007/s00428-020-02902-9 |
_version_ | 1783666232573034496 |
---|---|
author | van der Slot, Margaretha A. Hollemans, Eva den Bakker, Michael A. Hoedemaeker, Robert Kliffen, Mike Budel, Leo M. Goemaere, Natascha N. T. van Leenders, Geert J. L. H. |
author_facet | van der Slot, Margaretha A. Hollemans, Eva den Bakker, Michael A. Hoedemaeker, Robert Kliffen, Mike Budel, Leo M. Goemaere, Natascha N. T. van Leenders, Geert J. L. H. |
author_sort | van der Slot, Margaretha A. |
collection | PubMed |
description | The Grade group is an important parameter for clinical decision-making in prostate cancer. Recently, percent Gleason pattern 4 and presence of invasive cribriform and/or intraductal carcinoma (CR/IDC) have been recognized for their independent predictive value for prostate cancer outcome. There is sparse data on the inter-observer agreement for these pathologic features in practice. Our objectives were to investigate inter-observer variability of percent Gleason pattern and CR/IDC and to relate individual tumour scores to clinical outcome. Our cohort included 80 consecutive radical prostatectomies with a median follow-up 87.1 months (interquartile range 43.3–119.2), of which the slide with largest tumour volume was scored by six pathologists for Grade group (four tiers: 1, 2, 3 and 4/5), percent Gleason pattern 4 (four tiers: 0–25%, 26–50%, 51–75% and 76–100%) and presence of CR/IDC (two tiers: absent, present). The individual assignments were related to post-operative biochemical recurrence (20/80). Inter-observer agreement was substantial (Krippendorff’s α 0.626) for assessment of Grade group and moderate for CR/IDC (α 0.507) and percent Gleason pattern 4 (α 0.551). For each individual pathologist, biochemical recurrence rates incremented by Grade group and presence of CR/IDC, although such relation was less clear for percent Gleason pattern 4. In conclusion, inter-observer agreement for CR/IDC and percent Gleason pattern 4 is lower than for Grade groups, indicating awareness of these features needs further improvement. Grade group and CR/IDC, but not percent Gleason pattern 4 was related to biochemical recurrence for each pathologist, indicating overall validity of individual grade assignments despite inter-observer variability. |
format | Online Article Text |
id | pubmed-7969485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-79694852021-04-01 Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome van der Slot, Margaretha A. Hollemans, Eva den Bakker, Michael A. Hoedemaeker, Robert Kliffen, Mike Budel, Leo M. Goemaere, Natascha N. T. van Leenders, Geert J. L. H. Virchows Arch Original Article The Grade group is an important parameter for clinical decision-making in prostate cancer. Recently, percent Gleason pattern 4 and presence of invasive cribriform and/or intraductal carcinoma (CR/IDC) have been recognized for their independent predictive value for prostate cancer outcome. There is sparse data on the inter-observer agreement for these pathologic features in practice. Our objectives were to investigate inter-observer variability of percent Gleason pattern and CR/IDC and to relate individual tumour scores to clinical outcome. Our cohort included 80 consecutive radical prostatectomies with a median follow-up 87.1 months (interquartile range 43.3–119.2), of which the slide with largest tumour volume was scored by six pathologists for Grade group (four tiers: 1, 2, 3 and 4/5), percent Gleason pattern 4 (four tiers: 0–25%, 26–50%, 51–75% and 76–100%) and presence of CR/IDC (two tiers: absent, present). The individual assignments were related to post-operative biochemical recurrence (20/80). Inter-observer agreement was substantial (Krippendorff’s α 0.626) for assessment of Grade group and moderate for CR/IDC (α 0.507) and percent Gleason pattern 4 (α 0.551). For each individual pathologist, biochemical recurrence rates incremented by Grade group and presence of CR/IDC, although such relation was less clear for percent Gleason pattern 4. In conclusion, inter-observer agreement for CR/IDC and percent Gleason pattern 4 is lower than for Grade groups, indicating awareness of these features needs further improvement. Grade group and CR/IDC, but not percent Gleason pattern 4 was related to biochemical recurrence for each pathologist, indicating overall validity of individual grade assignments despite inter-observer variability. Springer Berlin Heidelberg 2020-08-20 2021 /pmc/articles/PMC7969485/ /pubmed/32815034 http://dx.doi.org/10.1007/s00428-020-02902-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article van der Slot, Margaretha A. Hollemans, Eva den Bakker, Michael A. Hoedemaeker, Robert Kliffen, Mike Budel, Leo M. Goemaere, Natascha N. T. van Leenders, Geert J. L. H. Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome |
title | Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome |
title_full | Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome |
title_fullStr | Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome |
title_full_unstemmed | Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome |
title_short | Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome |
title_sort | inter-observer variability of cribriform architecture and percent gleason pattern 4 in prostate cancer: relation to clinical outcome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969485/ https://www.ncbi.nlm.nih.gov/pubmed/32815034 http://dx.doi.org/10.1007/s00428-020-02902-9 |
work_keys_str_mv | AT vanderslotmargarethaa interobservervariabilityofcribriformarchitectureandpercentgleasonpattern4inprostatecancerrelationtoclinicaloutcome AT hollemanseva interobservervariabilityofcribriformarchitectureandpercentgleasonpattern4inprostatecancerrelationtoclinicaloutcome AT denbakkermichaela interobservervariabilityofcribriformarchitectureandpercentgleasonpattern4inprostatecancerrelationtoclinicaloutcome AT hoedemaekerrobert interobservervariabilityofcribriformarchitectureandpercentgleasonpattern4inprostatecancerrelationtoclinicaloutcome AT kliffenmike interobservervariabilityofcribriformarchitectureandpercentgleasonpattern4inprostatecancerrelationtoclinicaloutcome AT budelleom interobservervariabilityofcribriformarchitectureandpercentgleasonpattern4inprostatecancerrelationtoclinicaloutcome AT goemaerenataschant interobservervariabilityofcribriformarchitectureandpercentgleasonpattern4inprostatecancerrelationtoclinicaloutcome AT vanleendersgeertjlh interobservervariabilityofcribriformarchitectureandpercentgleasonpattern4inprostatecancerrelationtoclinicaloutcome |